Epinephrine recalls
Epinephrine products have been recalled 8 times, most recently on 16 Sep 2026. The recalling company is usually Cardinal Health. The most common reason is manufacturing (cgmp) deviations.
Total recalls8since 2020
Last 12 months3reported
Class I113% of total
Ongoing3latest 16 Sep 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 1 13%Class II 6 75%Class III 1 13%
Why epinephrine is recalled
Companies
Product types
By year
Ongoing epinephrine recalls
3 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS I | Epinephrine Injection, USP, 30 mg/ (1mg/mL)-Multiple-Dose Vial recalledEpinephrine | American Regent | Particulate Matter | Nationwide |
| Drug | CLASS III | Epinephrine Injection, USP, 1mg/mL single-dose vial recalledEpinephrine | Fresenius Kabi USA | Potency & Assay | Nationwide |
| Drug | CLASS II | Epinephrine Injection, USP, 1 mg/ (0.1 mg/mL) recalledEpinephrine | International Medication Systems | Sterility | Nationwide |
All epinephrine recalls, newest first
8 totalAbout this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.